Sex differences among patients with high risk receiving Ticagrelor with or without Aspirin after percutaneous coronary intervention: a subgroup analysis of the TWILIGHT randomized clinical trial
This is a prespecified secondary sub-analysis of the TWILIGHT trial that seeks to shed light on the association of the different baseline risk factors, namely advanced age and significant renal dysfunction, with a higher bleeding risk in women.
